Duration and Dose of Adjuvant Zoledronic Acid for Treatment of Early Breast Cancer-Reply

JAMA Oncol. 2022 Jan 1;8(1):171-172. doi: 10.1001/jamaoncol.2021.5768.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms* / drug therapy
  • Chemotherapy, Adjuvant
  • Diphosphonates / adverse effects
  • Female
  • Humans
  • Zoledronic Acid / therapeutic use

Substances

  • Diphosphonates
  • Zoledronic Acid